Summary
Allenex AB (Allenex), formerly LinkMed AB is a subsidiary of CareDx Inc, life science company that develops, manufactures, markets and provides sales of diagnostic products. It offers products such as olerup SSP; XM-ONE and pipeline; AB0 column, AB0 diagnostic test. Its diagnostics products are used for safe transplantation of blood stem cells and organs. Allenex AB0 column is used for transplantation between people of different blood groups and its AB0 diagnostics is used to tests that measures occurrence of blood group antibodies. The company caters its products to medical centers and laboratories, hospitals which is present in the transplantation of blood stem cells and organs. It also markets its products through its sales companies located in Austria, and the US. Allenex is headquartered in Stockholm, Sweden.
Allenex AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Allenex AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Allenex AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Allenex AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Allenex AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Allenex AB, Medical Devices Deals, 2011 to YTD 2017 9
Allenex AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Allenex AB, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
Alden Impact Capital Acquires 49.5% Stake In NovaHep From Allenex 11
Alden Impact Capital Acquires 49.6% Stake In Recopharma From Allenex 11
Acquisition 12
CareDx Acquires Allenex for up to USD35 Million 12
Allenex to Acquire Remaining Stake in Olerup SSP, AbSorber, Olerup International and Olerup for USD2.4 Million 14
Midroc Europe Acquires 36.3% Stake in Allenex for up to USD14.5 Million 15
Allenex To Sell 2.1% Stake In AnaMar To Koncentra For US$0.3 Million 16
Allenex Sells Stake In Pharmacolog i Uppsala For US$0.04 Million 17
Allenex AB - Key Competitors 18
Key Employees 19
Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21
List of Tables
Allenex AB, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Allenex AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Allenex AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Allenex AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Allenex AB, Deals By Therapy Area, 2011 to YTD 2017 8
Allenex AB, Medical Devices Deals, 2011 to YTD 2017 9
Allenex AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Alden Impact Capital Acquires 49.5% Stake In NovaHep From Allenex 11
Alden Impact Capital Acquires 49.6% Stake In Recopharma From Allenex 11
CareDx Acquires Allenex for up to USD35 Million 12
Allenex to Acquire Remaining Stake in Olerup SSP, AbSorber, Olerup International and Olerup for USD2.4 Million 14
Midroc Europe Acquires 36.3% Stake in Allenex for up to USD14.5 Million 15
Allenex To Sell 2.1% Stake In AnaMar To Koncentra For US$0.3 Million 16
Allenex Sells Stake In Pharmacolog i Uppsala For US$0.04 Million 17
Allenex AB, Key Competitors 18
Allenex AB, Key Employees 19
Allenex AB, Subsidiaries 20
List of Figures
Allenex AB, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Allenex AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Allenex AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Allenex AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Allenex AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Allenex AB, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Allenex AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Allenex AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Allenex AB, Medical Devices Deals, 2011 to YTD 2017 9